Eurofins Scientific SE (ERF.PA) stock: key figures, P/E, revenue and dividend

Health Care · Luxembourg · ISIN FR0014000MR3

Price
77.86 EUR
Market cap
14.52 bn EUR
P/E (2025)
30.65
P/S (2025)
1.99
Dividend yield
0.92 %
Net margin
6.51 %
Return on equity (ROE)
13.41 %
Return on assets (ROA)
4.32 %

Eurofins Scientific SE financials

Fiscal year20242025
Revenue6.95 bn EUR7.30 bn EUR
Gross profit4.71 bn EUR896.00 m EUR
Operating income897.80 m EUR963.70 m EUR
EBIT726.00 m EUR818.00 m EUR
Net income406.00 m EUR475.00 m EUR
Diluted EPS – continuing operations2.10 EUR2.54 EUR

Full history since 1996, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Eurofins Scientific SE

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, QA-QC programme, and food and dietary supplement labelling services; biopharma, and clinical diagnostics. The company also offers consumer product testing, which include sustainability, testing, certifications and approvals, expert services and regulatory, inspections, audits, consumer research and sensory evaluation, and training courses; cosmetics and personal care; and electrical and electronics laboratories services. In addition, it provides environment testing, including maritime, water, air, soil, building material, pollution, waste, fuel/oil, microplastics, and radioactivity testing; and food and feed testing that include allergen, audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, GMO, heavy metal, melamine, microbiology, molecular biology, mycotoxin, nutritional analyses, organic contaminants, pesticide, veterinary drug, vitamin, and residual DNA testing. Further, the company provides forensic, genomic, maritime, materials and engineering, REACH, and sensory and consumer services, as well as in vitro diagnostics and PSS insourcing solutions. The company was founded in 1987 and is headquartered in Luxembourg, Luxembourg.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 14.10.2026. Details in the risk notice.

Eurofins Scientific SE stock (ERF.PA): P/E, revenue, dividend | finmetric